References
1. Silva J., Flor-de-Lima F., Soares H., Guimaraes H. Off-label and unlicensed drug use in neonatology: reality in a Portuguese University Hospital. Acta Med Port. 2015; 28 (3): 297-306.
2. Gongalves A.C.S., Reis A.M.M., Margal A.C.G., Bouzada M.C.F. Use of unlicensed and off-label drugs in neonates in a Brazilian university hospital. Braz J Pharm Sci. 2018; 53 (2): e00252. DOI : https://doi.org/10.1590/s2175-97902017000300252
3. Gazarian M., Kelly M., McPhee J.R., Graudins L.V., Ward R.L., Campbell T.J. Off-label use of medicines: consensus recommendations for evaluating appropriateness. Med J Aust. 2006; 185 (10): 544-8. DOI: https://doi.org/10.5694/j.1326-5377.2006.tb00689.x PMID: 17115966.
4. Titova A.R., Asetskaya I.L., Polivanov V.A., Zyryanov S.K., Glagolev S.V. Off-label structure of drug prescriptions in children: analysis of the Russian database of spontaneous messages. Pediartiya [Pediatrics]. 2016; 95 (6): 75-84. (in Russian)
5. Koszma E.I.A., Bispo A.J.B., Santana I.A.O., Santos C.N.O. Use of off-label medications in a neonatal intensive care unit. Rev Paul Pediatr. 2021; 39: e2020063. DOI: https://doi.org/10.1590/1984-0462/2021/39/2020063 PMID: 33440406; PMCID: PMC7802993.
6. Pereverzev A.P., Lepakhin V.K. Modern view on the problem of using drugs in violation of the instructions. Meditsinskiy sovet [Medical Council]. 2013; ( 4): 110-1. (in Russian)
7. Mello M., Studdert D.M., Brennan T.A. Shifting terrain in the regulation of off-label promotion of pharmaceuticals. N Engl J Med. 2009; 360 (15): 1557-66. DOI: https://doi.org/10.1056/NEJMhle0807695
8. Schrier L., Hadjipanayis A., Stiris T., Ross-Russell R.I., Valiulis A., Turner M.A., et al. Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology. Eur J Pediatr. 2020; 179 (5): 839-47. DOI: https://doi.org/10.1007/s00431-019-03556-9 PMID: 31897842.
9. Declaration on Good Off-Label Use Practice. URL: //https://www.bram-council.eu/golup/wp-content/uploads/2017/11/GOLUP_Declaration.pdf
10. Aronson J.K., Ferner R.E. Unlicensed and off-label uses of medicines: definitions and clarification of terminology. Br J Clin Pharmacol. 2017; 83 (12): 2615-25. DOI: https://doi.org/10.1111/bcp.13394 Epub 2017 Sep 26. PMID: 28779556; PMCID: PMC5698582.
11. Gilyarevsky S.R. Prescribing medicines for indications not specified in the instructions («off-label»): a complex problem of modern clinical practice. Ratsional’naya farmakoterapiya v kardiologii [Rational Pharmacotherapy in Cardiology]. 2020; 16 (2): 324-34. DOI: https://doi.org/10.20996/1819-6446-2020-04-14 (in Russian)
12. Mustafina-Bredikhina D.M. The use of off-label medicines: International experience and prospects in Russia. Neonatologiya: novosti, mneniya, obuchenie [Neonatology: News, Opinions, Training]. 2015; (1): 77-9. (in Russian)
13. Karpova A.L., Mustafina-Bredikhina D.M., Priluchnaya I.A., et al. Conducting medical documentation in neonatology departments. In: A Guide for Neonatologists, Anesthesiologists, Resuscitators and Pediatricians: an educational and methodological manual. Moscow: RUDN, 2020: 192 p. (in Russian)